Preclinical studies on breast cancer cell lines demonstrated that, as expected, oestrogens rapidly induce VEGF expression, which is blocked by pure oestrogen antagonists (Ruohola et al, 1999; Hyder et al, 2000a). Here, VEGFA is linked to breast carcinoma.